IATI

Alpha Tau Medical Ltd. Appoints Ruth Alon to its Board of Directors

Retrieved on: 
Monday, March 21, 2022

JERUSALEM, March 21, 2022 /PRNewswire/ --Alpha Tau Medical Ltd. (Nasdaq: DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, today announced the appointment of Ms. Ruth (Ruti) Alon to its Board of Directors, effective immediately.

Key Points: 
  • JERUSALEM, March 21, 2022 /PRNewswire/ --Alpha Tau Medical Ltd. (Nasdaq: DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, today announced the appointment of Ms. Ruth (Ruti) Alon to its Board of Directors, effective immediately.
  • "We are pleased to welcome Ruti as the newest member of our Board of Directors," said Uzi Sofer, Chief Executive Officer and Chairman of Alpha Tau.
  • Ruti Alon added, "I have been following Alpha Tau from its inception, always believing in the technology and its potential.
  • Founded in 2016, Alpha Tau is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors.

Dalata Hotel Group PLC: Directorate Changes

Retrieved on: 
Thursday, October 28, 2021

Dublin and London | 28 October 2021: Dalata Hotel Group plc ("Dalata" or the "Group" or the "Company"), the largest hotel operator in Ireland with a growing presence in the United Kingdom, announces changes to its board.

Key Points: 
  • Dublin and London | 28 October 2021: Dalata Hotel Group plc ("Dalata" or the "Group" or the "Company"), the largest hotel operator in Ireland with a growing presence in the United Kingdom, announces changes to its board.
  • Dalata Hotel Group plc was founded in August 2007 and listed as a plc in March 2014.
  • For the first six months of 2021, Dalata reported revenue of 39.6 million and a loss after tax of 30.4 million.
  • Dalata is listed on the Main Market of Euronext Dublin (DHG) and the London Stock Exchange (DAL).